BostonGene

BostonGene to showcase its multimodal AI platform driving advances in drug development at the 2025 ASCO® Annual Meeting! Through six accepted studies—conducted independently and in collaboration with leading academic institutions—we’ll demonstrate how our platform uncovers novel biomarkers, enhances patient stratification and predicts therapeutic response across a wide range of tumor types. These findings highlight how we’re accelerating biomarker discovery and helping to optimize clinical trial design. Our executive team—including President and CEO Andrew Feinberg, Chief Commercial Officer Ferran Prat Escude, Chief Medical Officer Nathan Fowler, MD and Chief Scientific Officer Joe Lennerz—will be onsite at #ASCO25. To schedule a meeting, please email [email protected]. Read more: https://lnkd.in/eDtztM-t

BostonGene to showcase its multimodal AI platform driving advances in drug development at the 2025 ASCO® Annual Meeting! Through six accepted studies—conducted independently and in collaboration with leading academic institutions—we’ll demonstrate how our platform uncovers novel biomarkers, enhances patient stratification and predicts therapeutic response across a wide range of tumor types. These findings highlight how we’re accelerating biomarker discovery and helping to optimize clinical trial design. Our executive team—including President and CEO Andrew Feinberg, Chief Commercial Officer Ferran Prat Escude, Chief Medical Officer Nathan Fowler, MD and Chief Scientific Officer Joe Lennerz—will be onsite at #ASCO25. To schedule a meeting, please email [email protected]. Read more: https://lnkd.in/eDtztM-t

One week until we’re in Chicago for the 2025 ASCO® Annual Meeting! Email [email protected] to schedule a meeting! #ASCO25.

Meet with us at #ASCO25! BostonGene will showcase how our multimodal AI platform is accelerating oncology drug development—from biomarker discovery to patient stratification and smarter trial design. Email [email protected] to schedule a meeting during #ASCO25!

Join BostonGene’s Ferran Prat Escude—on saxophone—with the amazingly talented band The Checkpoints at the 2025 ASCO Annual Meeting! #ASCO25 Contact Mindon (Whalen) Laue to learn more about sponsorship opportunities or click here to purchase VIP tickets individually: https://lnkd.in/erc3ZSrx

Join us at the 2025 ASCO® Annual Meeting on May 31 – June 2 in Chicago! To schedule a meeting or learn more, email us at [email protected]! #ASCO25

Join us at the 2025 ASCO® Annual Meeting on May 31 – June 2 in Chicago! To schedule a meeting or learn more, email us at [email protected]! #ASCO25

This week at #AACR25, we were proud to present our research and highlight our collaboration with Dr. Carl Gay and Simon Heeke of MD Anderson Cancer Center! Abstract #1101 – "A Novel Machine Learning Classifier for SCLC Transcriptional Subtypes": In this study, BostonGene applied gradient-boosting machine learning models to refine small cell lung cancer (SCLC) subtypes originally developed by Gay et al. The model demonstrated strong validation performance, underscoring its potential clinical impact. Learn more: https://lnkd.in/ejaQ_VWq

✨What a night! ✨ We gathered at Girl and the Goat in Chicago to celebrate our remarkable 2025 BrightEdge - American Cancer Society Entrepreneurs cohort — an inspiring group of innovators working to change the future of cancer care. Over 100 founders, funders, supporters, and partners joined us at our annual BEE at AACR dinner for an evening of connection, collaboration, and big ideas. A heartfelt thank you to everyone who joined us, and a special shoutout to our generous sponsors BostonGene and Wilson Sonsini Goodrich & Rosati for making this celebration possible 🙏 The energy and vision in this room remind us why we do this work. Here’s to bold science, bold entrepreneurs — and accelerating impact together! #BrightEdgeEntrepreneurs #BEEatAACR #CancerInnovation #AACR2025 #LifeSciences #Oncology #BostonGene #WilsonSonsini Carol Curtis, Ph.D. Bianca Scimemi Ryan Margolis, PhD Stephen Curtis Jess Miciak, PhD Jennifer Fang Joe Lennerz Teresa Pham Nathan Fowler, MD Brittan McClanahan Andrea Linna Anu Parvatiyar Hannah M. Peterson, PhD Carole Spangler Vaughn, PhD, MBA Freddy Nguyen, MD, PhD Luba Perry, PhD Johanna Vincze Webb Yue Clare Lou, Ph.D. Kelly Caviglia Shubha K. Chakravarthy Debra Chao Luis Diaz Austin Draycott Chris Garabedian Dimitra Georganopoulou Veronica Gibaja Toumy G. Laura Hsieh, PhD Jean Jiang Susan Lappe Jennifer Lee Michael Marquardt Julia Monfrini Peev Pahini P. Norman Sharpless Leigh Zawel Bruce Zetter

What an unforgettable performance by The CheckPoints last night during the #AACR25 Welcome Reception! It was amazing to see Ferran Prat Escude, PhD, JD, showcasing his incredible talent on the saxophone!!! Ferran’s passion and energy — both on stage and in the business world — reflect a rare combination of creativity and leadership. We’re excited to have his leadership as we drive BostonGene’s next chapter in precision medicine.